TB Briefing Paper – October 2016
An overview of MSF’s programmatic use and clinical research with new TB treatment regimens tuberculosis
An overview of MSF’s programmatic use and clinical research with new TB treatment regimens tuberculosis
Outbreaks of methanol poisoning occur frequently on a global basis, affecting poor and vulnerable populations. Knowledge regarding methanol is limited, likely many cases and even outbreaks go unnoticed, with patients dying unnecessarily. The researchers, through
The importance of programmatically relevant operational research (OR) as a key driver to strengthen public health activities is well recognised. Moreover, building capacity of health workers from high-disease burden countries to independently conduct OR on
Ebola virus disease (EVD) is a highly lethal condition for which no specific treatment has proven efficacy. In September 2014, while the Ebola outbreak was at its peak, the World Health Organization released a short
While this paper is focused predominately on addressing diabetes mellitus (DM) as part of the strategy for ending TB, its content must also be viewed within the wider context of the Sustainable Development Goals (SDGs),
In August 2011, the World Health Organization (WHO) and the International Union Against Tuberculosis and Lung Disease (The Union) launched the Collaborative Framework for Care and Control of Tuberculosis (TB) and diabetes mellitus (DM) to
Nonsurgical adult male circumcision devices present an alternative to surgery where health resources are limited. This study aimed to assess the safety, feasibility, and acceptability of the PrePex device for adult male circumcision in Malawi.
Activism for the right to health is strong in India, and Indian civil society has traditionally been dynamic and occasionally successful in pushing for better HIV care. However, the same health and HIV activists who
The Médecins Sans Frontières (MSF) programme in Mumbai, India, has been providing treatment and care for HIV-infected MDR-TB patients since 2006. Of 174 patients enrolled in the clinic over the 10 years from 2006 to
Globally, there are very few children who have access to delamanid compared with the likely number who could benefit from it. Healthcare providers have described a number of challenges to the access of delamanid. The
The global burden of trauma and surgical conditions fall disproportionately on low- and middle-income countries (LMICs) [1, 2]. Inopportunely, developing countries are least equipped to provide essential surgical care [3]. As a result, LMICs have
Sign up for our emails and get deeper insight into world and work of MSF!